273 related articles for article (PubMed ID: 29706843)
1. NIRF Optical/PET Dual-Modal Imaging of Hepatocellular Carcinoma Using Heptamethine Carbocyanine Dye.
Zhang C; Zhao Y; Zhao N; Tan D; Zhang H; Chen X; Zhang H; An J; Shi C; Li M
Contrast Media Mol Imaging; 2018; 2018():4979746. PubMed ID: 29706843
[TBL] [Abstract][Full Text] [Related]
2. CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody.
Hernandez R; Sun H; England CG; Valdovinos HF; Ehlerding EB; Barnhart TE; Yang Y; Cai W
Theranostics; 2016; 6(11):1918-33. PubMed ID: 27570560
[TBL] [Abstract][Full Text] [Related]
3. Theranostic imaging of liver cancer using targeted optical/MRI dual-modal probes.
Chen Q; Shang W; Zeng C; Wang K; Liang X; Chi C; Liang X; Yang J; Fang C; Tian J
Oncotarget; 2017 May; 8(20):32741-32751. PubMed ID: 28416757
[TBL] [Abstract][Full Text] [Related]
4. The Application of Heptamethine Cyanine Dye DZ-1 and Indocyanine Green for Imaging and Targeting in Xenograft Models of Hepatocellular Carcinoma.
Zhang C; Zhao Y; Zhang H; Chen X; Zhao N; Tan D; Zhang H; Shi C
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635650
[TBL] [Abstract][Full Text] [Related]
5. Optical imaging of gastric cancer with near-infrared heptamethine carbocyanine fluorescence dyes.
Zhao N; Zhang C; Zhao Y; Bai B; An J; Zhang H; Wu JB; Shi C
Oncotarget; 2016 Aug; 7(35):57277-57289. PubMed ID: 27329598
[TBL] [Abstract][Full Text] [Related]
6. Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer.
Houghton JL; Zeglis BM; Abdel-Atti D; Aggeler R; Sawada R; Agnew BJ; Scholz WW; Lewis JS
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15850-5. PubMed ID: 26668398
[TBL] [Abstract][Full Text] [Related]
7. A Conjugate of Pentamethine Cyanine and
An FF; Kommidi H; Chen N; Ting R
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590411
[TBL] [Abstract][Full Text] [Related]
8. PET imaging of hepatocellular carcinoma by targeting tumor-associated endothelium using [
Lu Q; Long Y; Fan K; Shen Z; Gai Y; Liu Q; Jiang D; Cai W; Wan C; Lan X
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4000-4013. PubMed ID: 35763056
[TBL] [Abstract][Full Text] [Related]
9. Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical models.
Kasten BB; Jiang K; Cole D; Jani A; Udayakumar N; Gillespie GY; Lu G; Dai T; Rosenthal EL; Markert JM; Rao J; Warram JM
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1412-1426. PubMed ID: 31773232
[TBL] [Abstract][Full Text] [Related]
10. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using
Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X
Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096
[No Abstract] [Full Text] [Related]
11. Near-Infrared Heptamethine Cyanine Based Iron Oxide Nanoparticles for Tumor Targeted Multimodal Imaging and Photothermal Therapy.
Lee S; George Thomas R; Ju Moon M; Ju Park H; Park IK; Lee BI; Yeon Jeong Y
Sci Rep; 2017 May; 7(1):2108. PubMed ID: 28522841
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles-based pre-targeting strategy enables multi-modal imaging of orthotopic colon cancer and image-guided surgery.
Jing B; Qian R; Jiang D; Gai Y; Liu Z; Guo F; Ren S; Gao Y; Lan X; An R
J Nanobiotechnology; 2021 May; 19(1):151. PubMed ID: 34022897
[TBL] [Abstract][Full Text] [Related]
13. Heptamethine carbocyanine DZ-1 dye for near-infrared fluorescence imaging of hepatocellular carcinoma.
An J; Zhao N; Zhang C; Zhao Y; Tan D; Zhao Y; Bai B; Zhang H; Wu BJ; Shi C
Oncotarget; 2017 Aug; 8(34):56880-56892. PubMed ID: 28915639
[TBL] [Abstract][Full Text] [Related]
14. Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody.
Zettlitz KA; Tsai WK; Knowles SM; Kobayashi N; Donahue TR; Reiter RE; Wu AM
J Nucl Med; 2018 Sep; 59(9):1398-1405. PubMed ID: 29602820
[TBL] [Abstract][Full Text] [Related]
15. A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer.
Adumeau P; Carnazza KE; Brand C; Carlin SD; Reiner T; Agnew BJ; Lewis JS; Zeglis BM
Theranostics; 2016; 6(12):2267-2277. PubMed ID: 27924162
[TBL] [Abstract][Full Text] [Related]
16. Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.
Zhang H; Desai P; Koike Y; Houghton J; Carlin S; Tandon N; Touijer K; Weber WA
J Nucl Med; 2017 Jan; 58(1):29-35. PubMed ID: 27516447
[TBL] [Abstract][Full Text] [Related]
17. Heptamethine carbocyanine dye-mediated near-infrared imaging of canine and human cancers through the HIF-1α/OATPs signaling axis.
Shi C; Wu JB; Chu GC; Li Q; Wang R; Zhang C; Zhang Y; Kim HL; Wang J; Zhau HE; Pan D; Chung LW
Oncotarget; 2014 Oct; 5(20):10114-26. PubMed ID: 25361418
[TBL] [Abstract][Full Text] [Related]
18. PET/NIR Fluorescence Bimodal Imaging for Targeted Tumor Detection.
Xue X; Li Q; Zhang P; Xue Y; Zhao Y; Ye Y; Li J; Li Y; Zhao L; Shao G
Mol Pharm; 2023 Dec; 20(12):6262-6271. PubMed ID: 37948165
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.
Napp J; Stammes MA; Claussen J; Prevoo HAJM; Sier CFM; Hoeben FJM; Robillard MS; Vahrmeijer AL; Devling T; Chan AB; de Geus-Oei LF; Alves F
Int J Cancer; 2018 May; 142(10):2118-2129. PubMed ID: 29277891
[TBL] [Abstract][Full Text] [Related]
20. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
